A Phase 3 interventional study of MMRV and MMR (Priorix®) in Rubella, Varicella and Mumps, sponsored by GlaxoSmithKline. Completed at 41 sites in 2 countries. Open to participants aged 12 Months to 18 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-15.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies testing Measles-Mumps-Rubella Vaccine in Rubella — none open to participants now, none under way, none of them phase 3. Measles-Mumps-Rubella Vaccine · Rubella.
Among the 13 studies testing Measles-Mumps-Rubella Vaccine in Rubella, this one is the 10th largest by enrollment of the 12 interventional ones that give a count, is the only one that started in 2004, is one of 8 in phase 3, and was the 5th registered.
85 studies on the registry are indexed under Rubella; 11 are open to participants now.
Browse Rubella studies →None of the 13 studies testing Measles-Mumps-Rubella Vaccine in Rubella is open now. The open studies under Rubella, anywhere →
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 5 Rubella studies recruiting now, none set no upper age limit and 5 stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.
This study: 12 Months to 18 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2004.
This study's enrollment of 398 is below the median of 801 across 71 interventional studies indexed under Rubella.
Median enrollment 549 across the 12 interventional studies. Of the 13 that completed or were terminated, 6 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 13 have an industry lead sponsor. The 5 most frequent:
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
22 studies in Rubella by GlaxoSmithKline: 2 open now, 2 under way, 2 of them phase 3. Of 19 finished, 11 (58%) have results posted.
Among the 22 studies in Rubella by GlaxoSmithKline, this one is the 18th largest by enrollment of the 20 interventional ones that give a count, is the only one that started in 2004, is one of 13 in phase 3, and was the 8th registered.
GlaxoSmithKline’s Rubella studies by the year they started, since 2000.
None of the studies under way reaches primary completion within a year.
Among the 13 studies testing Measles-Mumps-Rubella Vaccine in Rubella, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among GlaxoSmithKline’s 22 in Rubella:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Follow-up to evaluate the immunogenicity and safety of three production lots of GSK Biologicals' MMRV vaccine given as a two-dose schedule to healthy children in their second year of life, as compared to separate administration of GSK Biologicals' measles-mumps-rubella (MMR) vaccine (Priorix®) and varicella vaccine (Varilrix®) in Germany \& Austria. Blood samples were collected at three time points during the follow-up period (Year 1, 2 \& 3). No new subjects will be enrolled in these follow-up phases of the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Seropositivity rate & antibody titers for MMRV at 1, 2 & 3 year
Occurrence of breakthrough cases & contacts with MMRV disease(s) for 3 years after vaccination
Plan to share: Yes — Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.
The record gives a start of Jul 2004, a primary completion of Dec 2004 and a completion of Dec 2004. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Measles-Mumps-Rubella Vaccine